# Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial

> **NCT07118059** · PHASE2 · NOT_YET_RECRUITING · sponsor: **North-West University, South Africa** · enrollment: 40 (estimated)

## Conditions studied

- Tuberculosis
- Inflammation Biomarkers
- Liver Function Tests
- Iron Status
- Metabolomics
- Nutritional Status
- Clinical Outcomes

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3 (EPA+DHA)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07118059
- **Lead sponsor:** North-West University, South Africa
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07118059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07118059, "Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07118059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
